You are reading premium content from The Dark Report, your primary resource for running an efficient and profitable laboratory.

Get Unlimited Access to The Dark Report absolutely FREE!

You have read 0 of 1 of your complimentary articles this month

Privacy Policy: We will never share your personal information.
August 28, 2017 Intelligence: Late Breaking Lab News - The Dark Intelligence Group

August 28, 2017 Intelligence: Late Breaking Lab News

Share on facebook
Share on twitter
Share on linkedin
Share on print
Share on email

Genetic testing for dogs is the goal of Embark Veterinary, of Boston, Mass. Founded in 2015, the company just raised $4.5 million from investors, including Anne Wojcicki, founder of 23andMe. Company executives say the genetic testing will help vets, pet owners, and breeders identify the disease risk of the dogs, as well as the animals’ ancestry. The test can help breeders identify which dogs are carriers for specific health conditions to help the breeder avoid breeding two carriers. The test costs $199 (compared to 23andMe’s price of $149 for a human genetic test).

MORE ON Embark 

Embark Veterinary says that it has a library of 200,000 genetic markers for canines. It can also identify 175 breeds. Consistent with the well-known fact that pet owners regularly pay their vet bills in cash, Embark believes there is demand for such a genetic test, pointing out that owners spent $66.8 billion on their pets last year.

SONORA QUEST TO ARRANGE LOANS FOR PATIENTS

Earlier this month, Sonora Quest Laboratories of Tempe, Ariz., agreed to work with CarePayment, a company that helps patients with medical bills. The press release stated: “CarePayment’s easy-to-understand 0.00% APR financing solutions [will be offered] to any patient who uses Sonora Quest Laboratories for their medical testing exceeding $100 through a simple process that requires no application and has no impact on credit scores.”

TRANSITIONS

  • Sherrie Perkins, MD, PhD, is the new CEO of ARUP Laboratories of Salt Lake City. Perkins has been with ARUP for 20 years and has served as a member of its executive management team for eight years.
  • Andrew Theurer is the new President at ARUP Laboratories. He was previously Senior Vice President and Chief Financial Officer at ARUP.
  • Laboratory Corporation of America announced that Brian Caveney, MD, JD, MPH, was selected for the newly-created position of enterprise-wide Chief Medical Officer. Caveney was previously at Blue Cross Blue Shield of North Carolina.
  • David Grenache, PhD, was appointed to be the first Chief Medical Officer for TriCore Reference Laboratories of Albuquerque, N.M. He comes to TriCore from the University of Utah and ARUP Laboratories.

That’s all the insider intelligence for this report.
Look for the next briefing on Monday, September 18, 2017.

 

Comments

Leave a Reply

Powered by Americaneagle.com

Hosted by Americaneagle.com, Inc.